State Ledger
Company profile

KYNTRA BIO, INC. CIK 921299

Ticker
KYNB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Francisco, CA 94133
Fiscal year end
2025 (FY)
Market Data
Close
$6.12
Change
+$0.29
Change %
4.97%
Volume
221

KYNB · trading date Oct 12, 2026 · previous close $5.83 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$6.44M
Net income
$183.45M
Total assets
$119.59M
Total liabilities
$115.12M
Stockholders' equity
-$30.04M
Cash & equivalents
$47.87M
Operating income
-$45.90M
Operating cash flow
-$4.77M
Capital expenditures
$38.0K

Fiscal year 2025, via 10-K filed 2026-03-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-712.7%
Net margin
2,848.6%
Free cash flow
-$4.81M
Free cash flow margin
-74.7%
Liabilities / assets
96.3%
Equity / assets
-25.1%
CapEx / revenue
0.6%
Operating cash flow / net income
-0.03×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $6.44M $183.45M $119.59M $115.12M -$30.04M
2024 $29.62M -$47.58M $214.53M $398.16M -$225.60M
2023 $46.80M -$284.23M $423.53M $585.73M -$204.17M
2022 $140.73M -$293.65M $610.09M $611.57M -$21.45M
2021 $235.31M -$290.02M $773.82M $544.71M $209.15M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-09
Financials filed via
Form 10-K
filed 2026-03-16

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Francisco, CA 94133
350 BAY STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:14 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies